ImmunityBio Inc. Common Stock vs WisdomTree Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.7 (market cap $10.51B), while WisdomTree Inc. Common Stock trades at $22.83 (market cap $3.44B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 3.1× WisdomTree Inc. Common Stock's market cap, and WisdomTree Inc. Common Stock pays a 0.53% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and WisdomTree Inc. Common Stock for 1 Days on average.
| IBRX | WT | |
|---|---|---|
Market Cap | $10.51B | $3.44B |
Volume | 10,445,785 | 2,480,128 |
Sector | Health | Financials |
52-Week High | $11.55 | $25.04 |
52-Week Low | $1.98 | $10.73 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $4.18B |
Dividend Yield | — | 0.53% |
Trailing returns across standard periods
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →WisdomTree provides exchange-traded products, model portfolios, and digital-asset-related products and services. Its digital offerings include tokenized funds, an institutional platform, and a blockchain-native wallet.
Read more on WT →